Hematopoiesis News Volume 12.11 | Mar 30 2021

    0
    44







    2021-03-30 | HN 12.11


    Hematopoiesis News by STEMCELL Technologies
    Vol. 12.11 – 30 March, 2021
    TOP STORY

    Targeting the AnxA1/Fpr2/ALX Pathway Regulates Neutrophil Function, Promoting Thromboinflammation Resolution in Sickle Cell Disease

    Administration of annexin A1 mimetic peptide AnxA1Ac2-26 ameliorated cerebral thrombotic responses in sickle transgenic mice via regulation of the FPR2/ALX pathway.
    [Blood]

    Abstract
    Image of erythroblasts which were simply & efficiently generated from PSCs using the STEMdiff Erythroid Kit.
    PUBLICATIONSRanked by the impact factor of the journal

    YBX1 Is Required for Maintaining Myeloid Leukemia Cell Survival by Regulating BCL2 Stability in an m6A-Dependent Manner

    Investigators showed that YBX1 was specifically required for maintaining myeloid leukemia cell survival in an m6A-dependent manner.
    [Blood]

    Abstract

    HOXBLINC Long Non-Coding RNA Activation Promotes Leukemogenesis in NPM1-Mutant Acute Myeloid Leukemia

    Scientists showed that the activation of HOXBLINC, a HOXB locus-associated long non-coding RNA, was a critical downstream mediator of NPM1c+-associated leukemic transcription program and leukemogenesis.
    [Nature Communications]

    Full Article

    Ontogenic Shifts in Cellular Fate Are Linked to Proteotype Changes in Lineage-Biased Hematopoietic Progenitor Cells

    Through deep coverage of the cellular proteome of fetal and adult lympho-myeloid multipotent progenitors, common lymphoid progenitors, and granulocyte-monocyte progenitors, researchers established that features traditionally attributed to adult hematopoiesis were conserved across lymphoid and myeloid lineages.
    [Cell Reports]

    Full ArticleGraphical Abstract

    Ddx41 Inhibition of DNA Damage Signaling Permits Erythroid Progenitor Expansion in Zebrafish

    Researchers demonstrated that loss of DEAD-box Helicase 41 (ddx41) led to anemia caused by diminished proliferation and defective differentiation of erythroid progenitors.
    [Haematologica]

    Abstract

    Reconciling Flux Experiments for Quantitative Modeling of Normal and Malignant Hematopoietic Stem/Progenitor Dynamics

    Investigators showed that in vivo flux experiments that came from different laboratories could all be reconciled into a single unifying model, even though they had previously been interpreted as being contradictory.
    [Stem Cell Reports]

    Full Article

    Endothelial Jak3 Expression Enhances Pro-Hematopoietic Angiocrine Function in Mice

    Scientists showed that Jak3 was expressed in endothelial cells across hematopoietic and non-hematopoietic organs, with heightened expression in the bone marrow.
    [Communications Biology]

    Full Article

    SETD2 Is Essential for Terminal Differentiation of Erythroblasts during Fetal Erythropoiesis

    Loss of Setd2 in hematopoietic cells ablated methyltransferase for histone 3 lysine-36 trimethylation, and led to anemia with a significant decrease in erythroid cells in the peripheral blood at E18.5.
    [Biochemical and Biophysical Research Communications]

    Abstract

    The Effect of Bone Marrow-Derived Mesenchymal Stem Cell Co-Transplantation with Hematopoietic Stem Cells on Liver Fibrosis Alleviation and Survival in Patients with Class III β-Thalassemia Major

    The authors evaluated the effect of co-transplantation of bone marrow-derived MSC with HSCs on the liver fibrosis alleviation and transplant outcomes in class III beta-thalassemia major.
    [Stem Cell Research & Therapy]

    Full Article
    New human primary cancer-sourced blood products, immune cell subsets, and more. Click to view products.
    REVIEWS

    First Blood: The Endothelial Origins of Hematopoietic Progenitors

    Sequential waves of definitive hematopoiesis arise from yolk sac and intembryonic hemogenic endothelia through an endothelial-to-hematopoietic transition.
    [Angiogenesis]

    Full Article

    Realizing Innate Potential: CAR-NK Cell Therapies for Acute Myeloid Leukemia

    While acute myeloid leukemia represents an intuitive disease in which to investigate chimeric antigen receptor (CAR) based immunotherapies, key biological differences to B-cell malignancies have complicated progress to date.
    [Cancers]

    Full Article
    INDUSTRY AND POLICY NEWS

    WPD Pharmaceuticals Announces Amended Sublicense Agreement with Moleculin Biotech for WP1066, WP1122 and Annamycin Drug Candidates

    WPD Pharmaceuticals Inc. announced that is has entered into an amended and restated sublicense agreement with Moleculin Biotech, Inc.
    [WPD Pharmaceuticals, Inc.]

    Press Release

    Rafael Pharmaceuticals Crosses Enrollment of 150 Patients in Pivotal Phase III Trial (ARMADA 2000) of CPI-613® (Devimistat) for Relapsed or Refractory Acute Myeloid Leukemia (AML)

    Rafael Pharmaceuticals, Inc. announced that it has crossed the enrollment of 150 patients in its Phase III clinical trial for patients with relapsed or refractory AML.
    [Rafael Pharmaceuticals, Inc. (GlobeNewswire, Inc.)]

    Press Release
    FEATURED EVENT

    British Society of Developmental Biology & Genetics Society Annual Spring Meeting

    April 19 – 23, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Assistant Professor – Hematology

    University of Washington – Seattle, Washington, United States

    Postdoctoral Fellow – Myeloma Tumor Microenvironment

    Moores Cancer Center – La Jolla, California, United States

    Medicinal Chemist – Muscle-Wasting, Neurodegeneration, and Oncology

    Almac – Belfast, Ireland

    Postdoctoral Position – Gene and Cell Therapy Development for Treatment of Primary Immune Deficiencies

    NIH National Institute of Allergy and Infectious Diseases – Bethesda, Maryland, United States

    Postdoctoral Fellow – Oncogenesis in Blood Malignancies

    City of Hope – Los Angeles, California, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Hematopoiesis News Twitter